Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 11 |
NetGPI | no | yes: 0, no: 11 |
Term | Name | Level | Count |
---|---|---|---|
GO:0016020 | membrane | 2 | 3 |
GO:0110165 | cellular anatomical entity | 1 | 3 |
Related structures:
AlphaFold database: E9AJ94
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 199 | 201 | PF00675 | 0.686 |
CLV_NRD_NRD_1 | 62 | 64 | PF00675 | 0.674 |
CLV_PCSK_KEX2_1 | 199 | 201 | PF00082 | 0.670 |
CLV_PCSK_KEX2_1 | 62 | 64 | PF00082 | 0.692 |
CLV_PCSK_SKI1_1 | 119 | 123 | PF00082 | 0.687 |
CLV_PCSK_SKI1_1 | 200 | 204 | PF00082 | 0.751 |
CLV_PCSK_SKI1_1 | 53 | 57 | PF00082 | 0.719 |
CLV_PCSK_SKI1_1 | 64 | 68 | PF00082 | 0.638 |
CLV_Separin_Metazoa | 74 | 78 | PF03568 | 0.353 |
DEG_APCC_DBOX_1 | 76 | 84 | PF00400 | 0.536 |
DOC_CYCLIN_yCln2_LP_2 | 105 | 108 | PF00134 | 0.523 |
DOC_PP2B_LxvP_1 | 104 | 107 | PF13499 | 0.504 |
DOC_PP4_FxxP_1 | 115 | 118 | PF00568 | 0.440 |
DOC_PP4_FxxP_1 | 203 | 206 | PF00568 | 0.478 |
DOC_USP7_MATH_1 | 125 | 129 | PF00917 | 0.526 |
DOC_USP7_MATH_1 | 187 | 191 | PF00917 | 0.557 |
DOC_USP7_MATH_1 | 19 | 23 | PF00917 | 0.633 |
DOC_USP7_MATH_1 | 2 | 6 | PF00917 | 0.704 |
DOC_USP7_MATH_1 | 227 | 231 | PF00917 | 0.417 |
DOC_USP7_MATH_1 | 76 | 80 | PF00917 | 0.492 |
DOC_USP7_MATH_1 | 81 | 85 | PF00917 | 0.504 |
LIG_14-3-3_CanoR_1 | 53 | 58 | PF00244 | 0.503 |
LIG_14-3-3_CanoR_1 | 62 | 67 | PF00244 | 0.469 |
LIG_14-3-3_CanoR_1 | 82 | 90 | PF00244 | 0.518 |
LIG_APCC_ABBA_1 | 204 | 209 | PF00400 | 0.541 |
LIG_BRCT_BRCA1_1 | 108 | 112 | PF00533 | 0.490 |
LIG_BRCT_BRCA1_1 | 88 | 92 | PF00533 | 0.543 |
LIG_eIF4E_1 | 91 | 97 | PF01652 | 0.457 |
LIG_EVH1_2 | 107 | 111 | PF00568 | 0.449 |
LIG_FHA_1 | 100 | 106 | PF00498 | 0.488 |
LIG_FHA_1 | 210 | 216 | PF00498 | 0.530 |
LIG_FHA_1 | 5 | 11 | PF00498 | 0.698 |
LIG_FHA_2 | 196 | 202 | PF00498 | 0.551 |
LIG_FHA_2 | 67 | 73 | PF00498 | 0.487 |
LIG_LIR_Apic_2 | 148 | 154 | PF02991 | 0.435 |
LIG_LIR_Apic_2 | 201 | 206 | PF02991 | 0.472 |
LIG_LIR_Gen_1 | 152 | 163 | PF02991 | 0.511 |
LIG_LIR_Nem_3 | 109 | 115 | PF02991 | 0.452 |
LIG_LIR_Nem_3 | 148 | 153 | PF02991 | 0.509 |
LIG_MLH1_MIPbox_1 | 108 | 112 | PF16413 | 0.502 |
LIG_MLH1_MIPbox_1 | 88 | 92 | PF16413 | 0.543 |
LIG_Pex14_2 | 111 | 115 | PF04695 | 0.463 |
LIG_SH2_CRK | 151 | 155 | PF00017 | 0.433 |
LIG_SH2_NCK_1 | 151 | 155 | PF00017 | 0.516 |
LIG_SH2_STAT5 | 151 | 154 | PF00017 | 0.449 |
LIG_SH2_STAT5 | 161 | 164 | PF00017 | 0.466 |
LIG_SH2_STAT5 | 91 | 94 | PF00017 | 0.453 |
LIG_SH3_3 | 164 | 170 | PF00018 | 0.460 |
LIG_SH3_3 | 22 | 28 | PF00018 | 0.537 |
LIG_SH3_3 | 46 | 52 | PF00018 | 0.502 |
LIG_SH3_3 | 7 | 13 | PF00018 | 0.694 |
LIG_SUMO_SIM_anti_2 | 229 | 235 | PF11976 | 0.497 |
LIG_SUMO_SIM_par_1 | 229 | 235 | PF11976 | 0.541 |
LIG_UBA3_1 | 36 | 41 | PF00899 | 0.475 |
MOD_CK2_1 | 117 | 123 | PF00069 | 0.527 |
MOD_CK2_1 | 195 | 201 | PF00069 | 0.536 |
MOD_GlcNHglycan | 188 | 192 | PF01048 | 0.741 |
MOD_GlcNHglycan | 21 | 24 | PF01048 | 0.552 |
MOD_GlcNHglycan | 69 | 72 | PF01048 | 0.732 |
MOD_GlcNHglycan | 93 | 96 | PF01048 | 0.697 |
MOD_GSK3_1 | 113 | 120 | PF00069 | 0.506 |
MOD_GSK3_1 | 145 | 152 | PF00069 | 0.533 |
MOD_GSK3_1 | 210 | 217 | PF00069 | 0.462 |
MOD_GSK3_1 | 58 | 65 | PF00069 | 0.451 |
MOD_LATS_1 | 51 | 57 | PF00433 | 0.535 |
MOD_N-GLC_1 | 86 | 91 | PF02516 | 0.737 |
MOD_NEK2_1 | 145 | 150 | PF00069 | 0.429 |
MOD_NEK2_1 | 195 | 200 | PF00069 | 0.537 |
MOD_NEK2_1 | 86 | 91 | PF00069 | 0.497 |
MOD_NEK2_1 | 97 | 102 | PF00069 | 0.387 |
MOD_PK_1 | 139 | 145 | PF00069 | 0.483 |
MOD_PKA_1 | 62 | 68 | PF00069 | 0.461 |
MOD_PKA_2 | 62 | 68 | PF00069 | 0.461 |
MOD_PKA_2 | 76 | 82 | PF00069 | 0.449 |
MOD_Plk_1 | 86 | 92 | PF00069 | 0.516 |
MOD_Plk_4 | 107 | 113 | PF00069 | 0.479 |
MOD_Plk_4 | 145 | 151 | PF00069 | 0.503 |
MOD_Plk_4 | 227 | 233 | PF00069 | 0.531 |
MOD_Plk_4 | 53 | 59 | PF00069 | 0.453 |
MOD_Plk_4 | 62 | 68 | PF00069 | 0.461 |
MOD_Plk_4 | 86 | 92 | PF00069 | 0.499 |
TRG_DiLeu_BaEn_1 | 218 | 223 | PF01217 | 0.526 |
TRG_DiLeu_BaEn_1 | 229 | 234 | PF01217 | 0.474 |
TRG_DiLeu_BaLyEn_6 | 100 | 105 | PF01217 | 0.519 |
TRG_ER_diArg_1 | 101 | 104 | PF00400 | 0.501 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1PDU2 | Leptomonas seymouri | 77% | 100% |
A0A0S4JQK8 | Bodo saltans | 33% | 90% |
A0A1X0P2T1 | Trypanosomatidae | 47% | 99% |
A0A3S5ISA4 | Trypanosoma rangeli | 50% | 100% |
A0A451EJ66 | Leishmania donovani | 95% | 100% |
A4H323 | Leishmania braziliensis | 88% | 100% |
A4HRC9 | Leishmania infantum | 95% | 100% |
C9ZXG7 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 52% | 89% |
E9ABZ7 | Leishmania major | 92% | 100% |
V5B2Q8 | Trypanosoma cruzi | 49% | 91% |